HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 29 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $466,000 | -85.9% | 1,411,500 | -69.2% | 0.23% | -85.4% |
| Q2 2020 | $3,297,000 | +127.7% | 4,579,500 | +2.8% | 1.56% | +75.9% |
| Q1 2020 | $1,448,000 | -3.5% | 4,455,500 | +108.4% | 0.88% | +28.9% |
| Q4 2019 | $1,501,000 | +2174.2% | 2,137,900 | +2037.9% | 0.69% | +1917.6% |
| Q3 2019 | $66,000 | +288.2% | 100,000 | +900.0% | 0.03% | +325.0% |
| Q2 2019 | $17,000 | -66.0% | 10,000 | -50.0% | 0.01% | -69.2% |
| Q1 2019 | $50,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,675,889 | $6,797,000 | 5.97% |
| PERKINS CAPITAL MANAGEMENT INC | 449,950 | $1,143,000 | 0.89% |
| Diametric Capital, LP | 116,754 | $297,000 | 0.23% |
| Granahan Investment Management | 924,300 | $2,348,000 | 0.17% |
| Requisite Energy Fund I LP | 100,000 | $254,000 | 0.10% |
| Requisite Capital Management, LLC | 100,000 | $254,000 | 0.10% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $635,000 | 0.09% |
| Kalos Management, Inc. | 74,420 | $179,000 | 0.09% |
| Crow Point Partners, LLC | 65,475 | $164,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 35,000 | $89,000 | 0.02% |